1. Delis DC, Kaplan E,. Kramer JH (2001): Delis-Kaplan Executive Function System: D-KEFS.
2. 2015 GB of DS (2017): Global Burden of Disease Study 2015 (GBD 2015) Obesity and Overweight Prevalence 1980—2015. United States: Institute for Health Metrics and Evaluation (IHME) Seattle.
3. Hales CM, Carroll MD, Fryar CD, Ogden CL (2020): Prevalence of obesity and severe obesity among adults: United States, 2017—2018. Retrieved from https://stacks.cdc.gov/view/cdc/85451
4. Organization WH, Others (2017): Obesity and overweight. Geneva. World Health Organization.
5. Huang Y, Lu Y, Huang Y-M, Wang M, Ling W, Sui Y, Zhao H-L (2020): Obesity in patients with COVID–19: a systematic review and meta-analysis. Metabolism 113: 154378.
6. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, et al. (2013): The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One 8: e65174.
7. Miller AA, Spencer SJ (2014): Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun 42: 10–21.
8. Rochette AD, Spitznagel MB, Strain G, Devlin M, Crosby RD, Mitchell JE, et al. (2016): Mild cognitive impairment is prevalent in persons with severe obesity. Obesity 24: 1427–1429.
9. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WT Jr, Luchsinger JA (2009): Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66: 336–342.
10. Bocarsly ME, Fasolino M, Kane GA, LaMarca EA, Kirschen GW, Karatsoreos IN, et al. (2015): Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function. Proc Natl Acad Sci U S A 112: 15731–15736.
